Individuals with stroke hemiplegia in chronic phase with spasticity Stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals who have given written consent to participate in this study from the individual or his/her surrogate. 2. Individuals aged between 18 and 90 years. 3. Individuals with stroke hemiplegia in the chronic phase of the disease for at least 6 months after the onset of the disease. 4. Individuals with a MAS of 1+ or higher for elbow flexors, wrist flexors, and finger flexors.
Exclusion criteria
Exclusion criteria: 1. Individuals with skin lesions in the treatment area 2. Individuals with acute inflammation 3. Individuals with thrombosis 4. Individuals who are pregnant or may become pregnant. 5. 5. Individuals with tumors 6. Individuals with multiple neurological disorders 7. 7. Individuals taking anticoagulants 8. Individuals with pain during voluntary movements in the treated area. 9. Individuals who have received botulinum toxin therapy within 4 months in the upper extremity of the intended intervention 10. Individuals who are deemed inappropriate by the attending physician, the principal investigator, or the principal research investigator and his or her research collaborators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Group differences in the immediate post-intervention effects of MAS on elbow flexor muscles | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Group differences in MAS of elbow flexor muscles after 1 month of intervention 2. Group differences in effect of MAS for wrist flexors and finger flexors immediately after intervention and after 1 month 3. Group differences in AOC, ROM of elbow extension and wrist dorsiflexion, ROM of hand extension, and tendon reflexes of elbow flexors and wrist flexors immediately after the intervention and 1 month after the intervention. 4. Recruitment, enrollment, compliance, and retention rates | — |
Contacts
Fujita Health University Hospital